|
Component | Botanical name | Family | Medicinal part | Observation | Dose | Effect | Mechanism of action | References |
|
Madecassoside | Centella asiatica | Umbelliferae | Whole plant | In vitro | 10~100 μM | Antiproliferation of HSFBs Promotion of apoptosis Diminishment of scar formation Facilitation of wound healing | Inhibition of HKF migration, F-actin filaments protein, and cytoskeletal protein. Promotion of nuclear shrinkage and mitochondrial membrane depolarization Condensation of chromatin and fragment of nuclei Inhibitory phosphorylation of p38, PI3K, AKT, and cofilin. Activation of caspase-3/caspase-9 Facilitation of Bax mRNA expression and decrease of Bcl-2 and MMP-13 mRNA expression | [11, 12] |
|
Genistein | Glycine max |
Leguminosae |
Fruit | In vitro | 25~100 μg/mL |
Anti-proliferation of HSFBs Suppression of mitosis Promotion of apoptosis | Inhibition of TPKs, increase of caspase-3, and decreases of α-SMA and Bcl-2 protein Enhancement of Bax protein Inhibition of types I/III precollagen mRNA expression, down-regulation of collagen I/III mRNA, reduction of PCNA expression, and inhibitory phosphorylation of c-Raf, MEK1/2, ERK1/2, and p38 Induction of morphology changes of apoptosis cells Inhibitory transdifferentiation of fibroblasts into myofibroblasts |
[13–17] |
37~370 µM | Decrease of G0-G1 phase and increase of G2-M phase Increase of C-JUN mRNA expression and decrease of FOS-B mRNA expression in skin keratinocytes Inhibitory mRNA expression of C-JUN and C-FOS in human fibroblasts In keloid fibroblasts, decrease of C-JUN and C-FOS mRNA expression at 37 µM, but enhancement at 370 µM |
|
Astragaloside IV | Astragalus Membranaceus | Leguminosae | Root | In vitro | 12.5~200 μM | Antiproliferation of HSFBs | Decrease of collagen I/collagen III and TGF-β1 secretion | [18] |
|
Tetrandrine | Stephania tetrandra |
Menispermaceae |
Root | In vitro | 10~80 μM |
Antiproliferation of HSFBs |
Inhibition of TGF-β1 mRNA transcription, promotion of Smad7 and MMP-1 mRNA expression, and inhibition of Smad2 mRNA expression Decrease of protein expression of collagen I/collagen III, Bcl-2, and MKP-1. Reduction of total collagen volume and S phase, increase of G0/G1 phase, and prevention of G0/G1 into G2 phase Inhibitory phosphorylation of MEK1/2 and ERK1/2 |
[19–22] |
In vivo | 1~10 mg/L |
Local injection
| 0.5~2 mg/L 50 mg/mL, 20 μL
|
|
Aloe-emodin | Rheum palmatum | Polygonaceae | Root, rhizome | In vitro | 20~80 mg/L | Antiproliferation of HSFBs | Increase of S phase | [23] |
|
5F | Pteris semipinnata |
Pteridaceae |
Whole plant | In vitro | 20~80 μg/mL | Antiproliferation of HPS |
Blockage of fibroblasts from G1 to S phase Decreased protein expression of TGF-β1 and type I collagen, increase of caspase-3, and reduction of total collagen and fibroblasts PCNA protein (cyclin) Inhibitory mRNA expression of type I/type III procollagen in SSSF |
[24–26] |
In vivo | 10~40 mg/L | Reduction of PS volume |
40~120 mg/L | Antiproliferation of SSSF |
Local injection | 20~80 mg/L
| Promotion of HPS apoptosis Decrease of hypertrophic index | Reduction of collagen fiber content |
|
Oxymatrine | Sophora japonica | Leguminosae | Root | In vitro | 0.125~1.0 mg/mL 2 μM | Antiproliferation of KFb and HFb Promotion of KFb apoptosis | Increase of S phase, inhibitory mRNA expression of collagen I/collagen III and reduction of protein expression of Smad3 and ERK1 Promotion of Smad7 protein expression Inhibition of p-Smad3 and nuclear translocation of Smad3 | [27, 28] |
|
Ginsenoside Rg3 (G-Rg3) | Panax ginseng | Araliaceae | Root, rhizome | In vivo Local injection | 3 mg/mL, 0.1 mL | Inhibition of HS Decrease of scar tissue fibrosis | Increase of protein expression of PCNA, Bax, caspase-3, and Cyt-c Decrease of Bcl-2 protein expression | [29, 30] |
|
Osthole | Cnidium monnieri | Apiaceae | Fruit | In vitro | 5~50 μM | Antiproliferation of HSFBs and Induction of apoptosis | Promotion of Bax mRNA expression and inhibition of Bcl-2 mRNA expression Decreases of TGF-β1 protein expression and facilitation of HSFBs shrinkage, chromatin condensation, membrane blebbing, apoptotic body formation, and DNA ladder formation | [31] |
|